We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Enzyme Indicates Risk of Heart Attack and Stroke

By Biotechdaily staff writers
Posted on 14 Jul 2008
A new test measures the amount of a specific enzyme that is present in blood when there is an active atherosclerotic process, which could lead to the rupture of plaque and cause a heart attack or a stroke. More...


Serologic markers with high specificity for advanced plaque can be used as a diagnostic tool in cardiovascular risk stratification. The new lipoprotein-associated phospholipase A2 (Lp-PLA2) blood test helps physicians to identify patients who could benefit from more aggressive therapy and it is especially recommended for intermediate and high-risk patients.

Lp-PLA2 is an inflammatory marker that is not affected by inflammation caused by infection or injury. Therefore, it is a more specific marker than C-reactive protein (CRP), which can be elevated from systemic infection, even when the vascular walls are healthy. High Lp-PLA2 in combination with high sensitivity (hs)-CRP increases the ability to determine risk level

SpectraCell Laboratories (Houston, TX, USA) has added the Lp-PLA2 to its cardiovascular range of products that are aimed at early detection of cardiovascular disease. Because 68% of heart attacks and strokes occur from blood clots, not narrowing of the arteries, and 50% of all heart attacks occur in patients with normal cholesterol values, the Lp-PLA2 test is often used in conjunction with advanced lipoprotein tests. SpectraCell's lipoprotein particle profile (LPP+) combines advanced cholesterol testing with additional independent risk factors such as Lp-PLA2, hs-CRP, insulin, and homocysteine.


Related Links:
SpectraCell Laboratories

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Platelet Function Analyzer
PL-12
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.